Awarded
FN Motol DNS – Atezolizumab
Original language: Czech
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- ROCHE s.r.o.
- Contract value
- CZK 47,770,240
- Bids received
- 1
- Published
- 18 Jul 2025
- Awarded
- 7 May 2025
- Contract start
- 7 May 2025
- Contract end
- 25 May 2026estimated
- Region
- Hlavní město Praha
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| FN Motol DNS – Bortezomib | Fakultní nemocnice v Motole | PROMEDICA PRAHA GROUP, a.s. | CZK 502,475 | 18 Jul 2025 |
| FN Motol DNS – Ivosidenib | Fakultní nemocnice v Motole | PHOENIX lékárenský velkoobchod, s.r.o. | CZK 15,925,444 | 18 Jul 2025 |
| FN Motol DNS – Klarithromycin - tablety a suspenze | Fakultní nemocnice v Motole | PHARMOS, a.s. | CZK 254,044 | 18 Jul 2025 |
| FN Motol DNS – Klarithromycin - infuze | Fakultní nemocnice v Motole | PROMEDICA PRAHA GROUP, a.s. | CZK 426,384 | 18 Jul 2025 |
| FN Motol DNS – Fingolimod | Fakultní nemocnice v Motole | PROMEDICA PRAHA GROUP, a.s. | CZK 2,063,466 | 18 Jul 2025 |
| FN Motol DNS – Niraparib | Fakultní nemocnice v Motole | GlaxoSmithKline, s.r.o. | CZK 34,653,340 | 18 Jul 2025 |